Article
A novel fully automated molecular diagnostic system (AMDS) for colorectal cancer mutation detection.
PloS one - 1 Jan 2013
Kitano Shiro, Myers Jamie, Nakamura Junko, Yamane Akio, Yamashita Mami, Nakayama Masato, Tsukahara Yusuke, Ushida Hiroshi, Liu Wanqing, Ratain Mark J, Amano Masahiko
Abstract excerpt
BACKGROUND: KRAS, BRAF and PIK3CA mutations are frequently observed in colorectal cancer (CRC). In particular, KRAS mutations are strong predictors for clinical outcomes of EGFR-targeted treatments such as cetuximab and panitumumab in metastatic colorectal cancer (mCRC). For mutation analysis, the current methods are time-consuming, and not readily available to all oncologists and pathologists. We have developed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
